Discover highlights from Biointron’s Lunch & Learn with MassBio, featuring HTP antibody platforms, alpaca VHH discovery, bispecific antibodies, and ADC development.
Biointron is excited to announce our participation in the Chinese Antibody Society 2024 Annual Meeting on May 11, 2024, in Cambridge, MA, USA. This premier event, themed "Beyond Borders: Advancements in Antibody-Based Therapeutics in Uncharted Territories," promises to showcase the latest developments in antibody therapeutics, with a focus on discovery, development, and manufacturing innovations.
The 4th Fc-Mediated Function Summit in Boston showcased Fc engineering advances. Biointron reports key insights driving next-generation antibody therapeutics.
AACR 2024 in San Diego spotlighted breakthroughs in cancer research. Biointron shares highlights on antibody therapeutics, discovery platforms, and translational science.
Here at the AACR Annual Meeting 2024, there are over 7000 abstracts, 300 poster presentations, and 50 symposia all about cancer research. A few topics that are currently trending in the conference include cancer vaccines, AI for diagnostics, novel immunotherapies, and antibody-drug conjugates (ADCs) as a new modality.
In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#
Biointron is thrilled to be part of the 4th Fc-Mediated Function Summit, a pivotal event focusing on the latest developments in FcRn, FcγR, and IgG, aiming to enhance related therapeutic applications. This unique conference, happening in Boston from April 16-18, 2024, will be gathering over 80 specialists in the field to share insights on molecular engineering and clinical outcomes.
Explore key highlights from Biologics 2024, including advances in ADCs, AI-driven drug discovery, peptide therapeutics, and next-generation biologics innovation.
Antibody Engineering & Therapeutics Europe 2024, scheduled from June 4th to 6th at the Excel London Platinum Suite, represents a pivotal gathering for professionals in the realm of antibody and protein therapeutic science and technology. Biointron invites you to join us at booth number 24.
The BIO International Convention 2024, scheduled for June 3-6 in San Diego, CA, is set to be an exciting event for the biotechnology industry. Biointron is excited to be a part of this prestigious event. We invite you to visit our booth, number 1512.
PepTalk 2024 delivered key insights into antibody development. Explore highlights on formulation, analytics, and modalities that shape the future of biotech innovation.
We are thrilled to announce Biointron's participation in the 20th Annual PEGS Boston (The Protein Engineering Summit), happening from May 13-17, 2024, in Boston, MA. Organized by CHI, this summit is the epitome of innovation in protein and antibody engineering, a field where Biointron has continually demonstrated its leadership.
Our 2023 year‑end networking and game night gathered scientists, partners, and friends to share results, swap ideas, and celebrate antibody discovery that will fuel the next year.
You can also contact us on the Scientist and Science Exchange marketplaces.
